SFRP2 and colorectal cancer: Furthermore, we aimed to evaluate the effect of recombinant human SFRP2 in colorectal cancer cell model (HCT116 cells) to understand its contribution to colorectal carcinogenesis, and to recommend new strategies for its use as a cancer biomarker.